|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Deferred offering costs | |||||||||
| Cash and investments held in Trust Account | |||||||||
| Total Assets | |||||||||
| Current Liabilities | |||||||||
| Accrued deferred offering cost | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Due to related parties | |||||||||
| Promissory note - related party | |||||||||
| Working capital loan - related party | |||||||||
| Total Current Liabilities | |||||||||
| Deferred underwriting commission payable | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 8,500,000 shares at redemption value of $10.81 and $10.52 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A Ordinary Shares | |||||||||
| Total class A ordinary shares subject to possible redemption, 8,500,000 shares at redemption value of $10.81 and $10.52 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders’ Deficit | |||||||||
| Ordinary shares value | |||||||||
| Class A Ordinary Shares | |||||||||
| Class B Ordinary Shares | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders’ Deficit | |||||||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
